Epigenetic events underlie the pathogenesis of sinonasal papillomas.
Benign inverted papillomas have been reported as monoclonal but lacking common genetic alterations identified in squamous cell carcinoma of the head and neck. Epigenetic changes alter the heritable state of gene expression and chromatin organization without change in DNA sequence. We investigated whether epigenetic events of aberrant promoter hypermethylation in genes known to be involved in squamous head and neck cancer underlie the pathogenesis of sinonasal papillomas. Ten formalin-fixed paraffin DNA samples from three inverted papilloma cases, two exophytic (everted) papilloma cases, and two cases with inverted and exophytic components were studied. DNA was obtained from microdissected areas of normal and papilloma areas and examined using a panel of 41 gene probes, designed to interrogate 35 unique genes for aberrant methylation status (22 genes) using the methylation-specific multiplex-ligation-specific polymerase assay. Methylation-specific PCR was employed to confirm aberrant methylation detected by the methylation-specific multiplex-ligation-specific polymerase assay. All seven cases indicated at least one epigenetic event of aberrant promoter hypermethylation. The CDKN2B gene was a consistent target of aberrant methylation in six of seven cases. Methylation-specific PCR confirmed hypermethylation of CDKN2B. Recurrent biopsies from two inverted papilloma cases had common epigenetic events. Promoter hypermethylation of CDKN2B was a consistent epigenetic event. Common epigenetic alterations in recurrent biopsies underscore a monoclonal origin for these lesions. Epigenetic events contribute to the underlying pathogenesis of benign inverted and exophytic papillomas. As a consistent target of aberrant promoter hypermethylation, CDKN2B may serve as an important epigenetic biomarker for gene reactivation studies.
Department of Otolaryngology/Head and Neck Surgery, Henry Ford Hospital, Detroit, MI 48202, USA.
Josena K
JK
Stephen
Lori E
LE
Vaught
Kang M
KM
Chen
Seema
S
Sethi
Veena
V
Shah
Michael S
MS
Benninger
Glendon M
GM
Gardner
Vanessa G
VG
Schweitzer
Mumtaz
M
Khan
Maria J
MJ
Worsham
D015331:Cohort Studies; D050762:Cyclin-Dependent Kinase Inhibitor p15 / Q000235:genetics* / Q000378:metabolism; D019175:DNA Methylation; D004273:DNA, Neoplasm / Q000032:analysis; D020868:Gene Silencing; D006801:Humans; D042282:Microdissection; D009364:Neoplasm Recurrence, Local / Q000235:genetics; D010212:Papilloma / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D010255:Paranasal Sinus Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D016133:Polymerase Chain Reaction; D011401:Promoter Regions, Genetic
C493966:CDKN2B protein, human; D050762:Cyclin-Dependent Kinase Inhibitor p15; D004273:DNA, Neoplasm